These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21598296)

  • 41. Synthesis of bridged piperazines with sigma receptor affinity.
    Weigl M; Wünsch B
    Eur J Med Chem; 2007 Oct; 42(10):1247-62. PubMed ID: 17420073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dual probes for the dopamine transporter and sigma1 receptors: novel piperazinyl alkyl-bis(4'-fluorophenyl)amine analogues as potential cocaine-abuse therapeutic agents.
    Cao J; Kulkarni SS; Husbands SM; Bowen WD; Williams W; Kopajtic T; Katz JL; George C; Newman AH
    J Med Chem; 2003 Jun; 46(13):2589-98. PubMed ID: 12801223
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
    Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thiophene bioisosteres of spirocyclic sigma receptor ligands. 1. N-substituted spiro[piperidine-4,4'-thieno[3,2-c]pyrans].
    Oberdorf C; Schepmann D; Vela JM; Diaz JL; Holenz J; Wünsch B
    J Med Chem; 2008 Oct; 51(20):6531-7. PubMed ID: 18816044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design and synthesis of N‑(benzylpiperidinyl)‑4‑fluorobenzamide: A haloperidol analog that reduces neuropathic nociception via σ
    Déciga-Campos M; Melo-Hernández LA; Torres-Gómez H; Wünsch B; Schepmann D; González-Trujano ME; Espinosa-Juárez J; López-Muñoz FJ; Navarrete-Vázquez G
    Life Sci; 2020 Mar; 245():117348. PubMed ID: 31981633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain.
    Kort ME; Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Johnson MS; Pacofsky GJ; Thomas JB; Carroll WA; Krambis MJ; Liu D; Shieh CC; Zhang X; Hernandez G; Mikusa JP; Zhong C; Joshi S; Honore P; Roeloffs R; Marsh KC; Murray BP; Liu J; Werness S; Faltynek CR; Krafte DS; Jarvis MF; Chapman ML; Marron BE
    J Med Chem; 2008 Feb; 51(3):407-16. PubMed ID: 18176998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis of sigma receptor ligands with unsymmetrical spiro connection of the piperidine moiety.
    Jasper A; Schepmann D; Lehmkuhl K; Vela JM; Buschmann H; Holenz J; Wünsch B
    Eur J Med Chem; 2009 Nov; 44(11):4306-14. PubMed ID: 19709783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel vanilloid receptor-1 antagonists: 2. Structure-activity relationships of 4-oxopyrimidines leading to the selection of a clinical candidate.
    Doherty EM; Fotsch C; Bannon AW; Bo Y; Chen N; Dominguez C; Falsey J; Gavva NR; Katon J; Nixey T; Ognyanov VI; Pettus L; Rzasa RM; Stec M; Surapaneni S; Tamir R; Zhu J; Treanor JJ; Norman MH
    J Med Chem; 2007 Jul; 50(15):3515-27. PubMed ID: 17585750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2).
    Fichna J; do-Rego JC; Chung NN; Lemieux C; Schiller PW; Poels J; Broeck JV; Costentin J; Janecka A
    J Med Chem; 2007 Feb; 50(3):512-20. PubMed ID: 17266203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NR2B-selective N-methyl-D-aspartate antagonists: synthesis and evaluation of 5-substituted benzimidazoles.
    McCauley JA; Theberge CR; Romano JJ; Billings SB; Anderson KD; Claremon DA; Freidinger RM; Bednar RA; Mosser SD; Gaul SL; Connolly TM; Condra CL; Xia M; Cunningham ME; Bednar B; Stump GL; Lynch JJ; Macaulay A; Wafford KA; Koblan KS; Liverton NJ
    J Med Chem; 2004 Apr; 47(8):2089-96. PubMed ID: 15056006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new metabotropic glutamate receptor agonist with in vivo anti-allodynic activity.
    Stanley NJ; Hutchinson MR; Kvist T; Nielsen B; Mathiesen JM; Bräuner-Osborne H; Avery TD; Tiekink ER; Pedersen DS; Irvine RJ; Abell AD; Taylor DK
    Bioorg Med Chem; 2010 Aug; 18(16):6089-98. PubMed ID: 20638290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation of insulin release by adenosine A1 receptor agonists and antagonists in INS-1 cells: the possible contribution of 86Rb+ efflux and 45Ca2+ uptake.
    Töpfer M; Burbiel CE; Müller CE; Knittel J; Verspohl EJ
    Cell Biochem Funct; 2008 Dec; 26(8):833-43. PubMed ID: 18979526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis of chiral 1-[omega-(4-chlorophenoxy)alkyl]-4-methylpiperidines and their biological evaluation at sigma1, sigma2, and sterol delta8-delta7 isomerase sites.
    Berardi F; Loiodice F; Fracchiolla G; Colabufo NA; Perrone R; Tortorella V
    J Med Chem; 2003 May; 46(11):2117-24. PubMed ID: 12747784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis of cycloalkane-annelated 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines and their evaluation as 5-HT6 receptor antagonists.
    Ivachtchenko AV; Dmitriev DE; Golovina ES; Dubrovskaya ES; Kadieva MG; Koryakova AG; Kysil VM; Mitkin OD; Tkachenko SE; Okun IM; Vorobiov AA
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2133-6. PubMed ID: 20207539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and structure-affinity relationships of novel spirocyclic sigma receptor ligands with furopyrazole structure.
    Schläger T; Schepmann D; Würthwein EU; Wünsch B
    Bioorg Med Chem; 2008 Mar; 16(6):2992-3001. PubMed ID: 18221879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel thienopyrimidinones as mGluR1 antagonists.
    Kim Y; Kim J; Kim S; Ki Y; Seo SH; Tae J; Ko MK; Jang HS; Lim EJ; Song C; Cho Y; Koh HY; Chong Y; Choo IH; Keum G; Min SJ; Choo H
    Eur J Med Chem; 2014 Oct; 85():629-37. PubMed ID: 25127154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel σ
    Kopp N; Holtschulte C; Börgel F; Lehmkuhl K; Friedland K; Civenni G; Laurini E; Catapano CV; Pricl S; Humpf HU; Schepmann D; Wünsch B
    Eur J Med Chem; 2021 Jan; 210():112950. PubMed ID: 33148494
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and Biological Evaluation of Novel σ1 Receptor Ligands for Treating Neuropathic Pain: 6-Hydroxypyridazinones.
    Cao X; Chen Y; Zhang Y; Lan Y; Zhang J; Xu X; Qiu Y; Zhao S; Liu X; Liu BF; Zhang G
    J Med Chem; 2016 Apr; 59(7):2942-61. PubMed ID: 27003636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).
    Pallavicini M; Budriesi R; Fumagalli L; Ioan P; Chiarini A; Bolchi C; Ugenti MP; Colleoni S; Gobbi M; Valoti E
    J Med Chem; 2006 Nov; 49(24):7140-9. PubMed ID: 17125266
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Two prodrugs of potent and selective GluR5 kainate receptor antagonists actives in three animal models of pain.
    Dominguez E; Iyengar S; Shannon HE; Bleakman D; Alt A; Arnold BM; Bell MG; Bleisch TJ; Buckmaster JL; Castano AM; Del Prado M; Escribano A; Filla SA; Ho KH; Hudziak KJ; Jones CK; Martinez-Perez JA; Mateo A; Mathes BM; Mattiuz EL; Ogden AM; Simmons RM; Stack DR; Stratford RE; Winter MA; Wu Z; Ornstein PL
    J Med Chem; 2005 Jun; 48(13):4200-3. PubMed ID: 15974569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.